Vanguard Fiduciary Trust
AIM

Vanguard Fiduciary Trust’s AIM ImmunoTech AIM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Hold
17,519
– – ﹤0.01% 4062
2026
Q1 		$10.2K Buy
+17,519
New +$17.7K ﹤0.01% 4000

Other funds holding AIM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Vanguard Fiduciary Trust's AIM Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its AIM ImmunoTech (AIM) position steady in Q2 2026 at 17,519 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4062.

Vanguard Fiduciary Trust first reported a position in AIM in Q1 2026 and has held it in 2 quarters since. The position peaked at $10.2K in Q1 2026. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • Vanguard Fiduciary Trust held 17,519 shares of AIM ImmunoTech worth $4.97K as of Q2 2026.
  • Vanguard Fiduciary Trust left its AIM ImmunoTech share count unchanged in Q2 2026.
  • AIM ImmunoTech made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4062 holding.
  • Vanguard Fiduciary Trust first reported a position in AIM ImmunoTech in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's AIM ImmunoTech position peaked at $10.2K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.